EUVIMEDEUVIMED entdecken
Open Access

Observed Prevalence of Congenital Situs Inversus in the United States Before and During the SARS ‐ CoV ‐2 Pandemic, 2017–2022

Janet D Cragan iD, Sook-Ja Cho, Nina Forestieri iD, Michele Hort, Eirini Nestoridi, Cynthia A Moore, Erin Stallings, Elizabeth B Gray, Jennita Reefhuis

Birth Defects Research · 2024

DOI: 10.1002/bdr2.2424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Birth Defects Research, 2024. Verfasst von Janet D Cragan und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: COVID-19, Situs Inversus, SARS-CoV-2, Pandemics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Reports from China describe an increase in the frequency of fetal situs inversus in 2023 after the country's “zero‐Covid” policy was lifted, suggesting an association with maternal SARS‐CoV‐2 infection. However, a report of birth defects surveillance data from Scandinavia observed no sustained increase during the SARS‐CoV‐2 pandemic (2020–2022 vs. 2018–2019). We examined birth defects surveillance data to assess any increase in situs inversus in the U.S. during the SARS‐CoV‐2 pandemic.

Methods

We combined data from four population‐based birth defects programs in Massachusetts, Minnesota, North Carolina, and Atlanta, Georgia, to compare the prevalence of situs inversus among infants and fetuses delivered before (2017–2019) and during (2021–2022) the SARS‐CoV‐2 pandemic. We defined situs inversus as mirror‐image transposition of the heart and/or other organs, or primary ciliary dyskinesis with situs inversus, excluding isolated dextrocardia. The programs varied in the pregnancy outcomes included (live births ± non‐live births); all included both prenatal and postnatal diagnoses.

Results

We identified 294 infants and fetuses with situs inversus (6.8% non‐live births). We estimated the combined prevalence per 10,000 live births as 1.72 during the pandemic versus 1.71 before the pandemic (OR = 1.005; 95% CI: 0.778–1.297). The estimated annual prevalence ranged from 1.41 in 2017 to 2.21 in 2019 with no significant trend across the study period ( p = 0.39).

Conclusions

We did not observe an increase in situs inversus during the SARS‐CoV‐2 pandemic. Because information about SARS‐CoV‐2 infection among individual pregnancies was not available from all programs, we could not assess a specific association with maternal infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Situs InversusSARS-CoV-2PandemicsHumansFemalePrevalencePregnancyUnited StatesInfant, NewbornPregnancy Complications, InfectiousMalePregnancy Outcome

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2birth defectlateralitypandemicprevalencesitus inversus

Autor:innen und Institutionen

  • National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Minnesota Department of Health, Minnesota Birth Defects Information System, St Paul, Minnesota, USA.
  • North Carolina Birth Defects Monitoring Program, State Center for Health Statistics, Raleigh, North Carolina, USA.
  • Massachusetts Birth Defects Monitoring Program, Massachusetts Department of Public Health, Boston, Massachusetts, USA.
  • Goldbelt Professional Services, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

ORCID-Profile: Janet D Cragan, Nina Forestieri

Förderung

  • Intramural CDC HHS

Zitieren

APA

Cragan, J. D., Cho, S. J., Forestieri, N., Hort, M., Nestoridi, E., Moore, C. A., Stallings, E., Gray, E. B., & Reefhuis, J. (2024). Observed Prevalence of Congenital Situs Inversus in the United States Before and During the SARS ‐ CoV ‐2 Pandemic, 2017–2022. Birth Defects Research. https://doi.org/10.1002/bdr2.2424

Vancouver

Cragan JD, Cho SJ, Forestieri N, Hort M, Nestoridi E, Moore CA, et al. Observed Prevalence of Congenital Situs Inversus in the United States Before and During the SARS ‐ CoV ‐2 Pandemic, 2017–2022. Birth Defects Research. 2024. doi:10.1002/bdr2.2424

BibTeX
@article{Cragan2024,
  author = {Cragan, Janet D and Cho, Sook-Ja and Forestieri, Nina and Hort, Michele and Nestoridi, Eirini and Moore, Cynthia A and Stallings, Erin and Gray, Elizabeth B and Reefhuis, Jennita},
  title = {Observed Prevalence of Congenital Situs Inversus in the United States Before and During the SARS ‐ CoV ‐2 Pandemic, 2017–2022},
  journal = {Birth Defects Research},
  year = {2024},
  doi = {10.1002/bdr2.2424}
}
Kostenlos starten →